
CAR-T Therapy Offers Hope for Aggressive Childhood Brain Tumors
A new study published in Nature reveals promising results for CAR-T therapy in treating diffuse intrinsic pontine gliomas (DIPG), a highly aggressive childhood brain tumor. Led by Michelle Monje-Deisseroth at Stanford University, the trial showed that four out of eleven patients experienced significant tumor reduction, with one patient remaining in complete remission 30 months post-treatment. Despite the high mortality rate, these findings offer hope for a condition previously deemed untreatable.


